dasiprotimut-T

[email protected]
dasiprotimut-T
Trade Name Biovaxid
Orphan Indication Follicular lymphoma
USA Market Approval USA
USA Designation Date 2009-10-28 00:00:00
Sponsor Biovest International, Inc.;324 S. Hyde Park Avenue;Tampa, Florida, 33606
Related Access Program
Kite, A Gilead Company – Relapsed/Refractory Transformed Follicular Lymphoma Kite Pharma, Inc. – Relapsed/Refractory Transformed Follicular Lymphoma Kite Pharma, Inc. – Relapsed/Refractory Transplant Ineligible Transformed Follicular Lymphoma